Skip to main content
logo
Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.950
+0.020 (0.51%)
Aug 7, 2025, 4:00 PM - Market closed

Endeavor Group Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--0.180.561.534.84
Revenue Growth (YoY)
---66.97%-63.50%-68.46%85.72%
Cost of Revenue
--1.914.765.896.39
Gross Profit
---1.73-4.2-4.37-1.55
Selling, General & Admin
4.034.565.556.034.995.8
Operating Expenses
4.034.565.556.034.995.8
Operating Income
-4.03-4.56-7.28-10.24-9.35-7.35
Interest Expense
------0.77
Interest & Investment Income
-00.010.050-
Other Non Operating Income (Expenses)
-0.18-0.15-0.05-0.02-0.080.79
EBT Excluding Unusual Items
-4.21-4.71-7.32-10.21-9.44-7.33
Gain (Loss) on Sale of Assets
--1.76---
Other Unusual Items
----0.66-0.08
Pretax Income
-4.21-4.71-5.57-10.21-8.78-7.41
Earnings From Continuing Operations
-4.21-4.71-5.57-10.21-8.78-7.41
Earnings From Discontinued Operations
------10.84
Net Income
-4.21-4.71-5.57-10.21-8.78-18.24
Net Income to Common
-4.21-4.71-5.57-10.21-8.78-18.24
Shares Outstanding (Basic)
111100
Shares Outstanding (Diluted)
111100
Shares Change (YoY)
17.59%19.55%11.91%38.13%157.89%392.56%
EPS (Basic)
-4.60-5.23-7.41-15.19-18.04-96.70
EPS (Diluted)
-4.60-5.23-7.41-15.19-18.04-96.70
Free Cash Flow
-4.13-3.88-7.09-8.18-7.92-17.74
Free Cash Flow Per Share
-4.52-4.32-9.43-12.18-16.28-94.05
Gross Margin
-----286.04%-32.04%
Operating Margin
---3954.89%-1837.52%-612.97%-151.94%
Profit Margin
---3026.63%-1832.32%-575.10%-377.06%
Free Cash Flow Margin
---3855.43%-1469.12%-519.13%-366.74%
EBITDA
-4.02-4.55-7.17-10.04-9.13-7.06
EBITDA Margin
------145.91%
D&A For EBITDA
00.010.110.20.220.29
EBIT
-4.03-4.56-7.28-10.24-9.35-7.35
EBIT Margin
------151.94%
Revenue as Reported
--0.180.561.534.84
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q